胃腸道支架市場報告：趨勢、預測和競爭分析（至2035年）

全球胃腸道支架市場前景廣闊，預計在醫院、門診手術中心和專科診所都將迎來發展機會。全球胃腸道支架市場預計將以5.1%的複合年成長率成長，從2026年到2035年達到約9.58億美元。推動該市場成長的主要因素包括胃腸道疾病盛行率的上升、對微創治療需求的成長以及先進支架技術的廣泛應用。

• 根據 Lucintel 的預測，在預測期內，膽道支架預計將成為成長最快的產品類型。
• 從申請量來看，醫院預計將呈現最高的成長率。
• 從區域來看，預計北美在預測期內將呈現最高的成長率。

胃腸支架市場的新趨勢

胃腸道支架市場正經歷快速成長，這主要得益於技術進步、胃腸道疾病盛行率上升以及全球人口老化。隨著醫療專業人員尋求針對複雜胃腸道疾病的微創治療方法，創新支架設計和材料應運而生，旨在改善患者預後。此外，監管部門的核准和適應症的擴大也為市場帶來了更多機會。這些發展正在改變胃腸道支架的應用模式，使治療更加有效、便捷，並能更好地滿足患者需求。對於希望利用不斷變化的市場動態並改善臨床實踐的利害關係人相關人員，了解這些趨勢至關重要。

• 技術創新：可生物分解和藥物釋放型胃腸道支架的研發正在革新治療方案。這些先進的支架減少了取出手術的必要性，並有助於預防血管再阻塞。材料和設計的創新提高了柔軟性、耐用性和生物相容性，從而改善了患者的舒適度和治療效果。隨著研究的深入，這些創新有望為胃腸道支架治療樹立新的標準，拓展其應用範圍，並提高長期療效。
• 包括食道癌、食道狹窄和克隆氏症在內的胃腸道疾病日益增多，推動了對胃腸道支架的需求。這些疾病在全球老化社會中尤其呈現上升趨勢，因此治療方法。隨著醫療專業人員尋求有效解決方案來應對複雜的胃腸道疾病，這一趨勢正在促進市場成長，並促使醫院和診所更多地採用支架置入術。
• 適應症範圍擴大：胃腸道支架最初主要用於治療惡性梗阻，如今擴大用於治療良性疾病，例如狹窄和瘻管。這種應用範圍的擴大拓寬了市場，並推動了支架設計的創新，以適應不同的適應症。微創技術能夠治療更廣泛的胃腸道疾病，這不僅改善了患者照護，縮短了住院時間，也進一步促進了市場成長。
• 監管核准和報銷政策：監管支持的加強和優惠的報銷政策正在推動市場擴張。 FDA和EMA等監管機構對新型支架產品的核准，確保了其安全性和有效性，並促進了產品的普及應用。此外，保險覆蓋範圍和報銷機制也提高了治療的可及性，從而刺激了市場需求。這些監管和政策方面的進步對於市場參與企業推出創新產品和拓展業務範圍至關重要。
• 微創手術的廣泛應用：從傳統外科手術轉向微創內視鏡手術是一個顯著的趨勢。胃腸道支架在這轉變過程中發揮核心作用，為患者提供了一種疼痛更輕、恢復更快的選擇。技術進步和臨床醫生技能的提升推動了這一趨勢，促使手術量不斷增加。以患者為中心的護理和成本效益的提升進一步加速了胃腸道支架的應用，改變了胃腸病學的治療模式。

總之，這些趨勢正透過促進創新、拓展臨床應用和改善患者預後，全面改變胃腸支架市場。它們正在推動市場成長，加速新產品開發，並重塑胃腸醫學的治療策略。

胃腸道支架市場近期趨勢

胃腸道支架市場正經歷快速成長，這主要得益於技術進步、胃腸道疾病盛行率的上升以及全球醫療基礎設施的擴展。支架設計和材料的創新正在改善患者的治療效果，而公眾意識的提高和診斷率的提升也推動了市場需求。此外，策略合作和監管核准也加速了市場擴張。這些發展正在改變市場格局，為製造商和醫療服務提供者創造了新的機遇，以拓展治療方案並提高患者的生活品質。

• 微創手術需求日益成長：微創治療的普及推動了胃腸道支架市場的發展。更短的恢復時間和更低的併發症風險促使患者傾向於選擇創傷較小的治療方案。技術創新催生了更靈活、更耐用、生物相容性更好的支架，提高了手術的安全性和有效性。這一趨勢正在擴大患者群體，並提高全球醫院和診所的採用率，從而顯著促進市場成長。
• 支架材料和設計的創新：生物材料和設計的進步正在革新胃腸道支架。新型材料，例如可生物分解支架和藥物釋放型支架，透過減少血管再阻塞和支架移位等併發症，改善了患者的治療效果。設計上的改進，例如更高的柔軟性和滲透性，使得支架的精準放置和監測成為可能。這些創新正在拓展支架的適應症，吸引更多醫療專業人員，並透過提高療效和安全性來提升市場收入。
• 胃腸道疾病（包括食道癌、胃癌和大腸癌，以及狹窄和阻塞等疾病）的日益普遍，推動了對胃腸道支架的需求。人口老化和生活方式因素加劇了這一趨勢。這些疾病負擔的加重，使得有效治療方法的需求日益迫切，而胃腸道支架已成為必不可少的工具。患病率的上升與市場銷售額的成長直接相關，從而刺激了該領域持續不斷的研發。
• 策略聯盟與監管核准：生技公司、醫療設備製造商和醫療服務提供者之間的合作正在加速創新和市場滲透。新興市場的監管核准正在開闢新的銷售管道。這些聯盟透過促進先進支架技術的開發和簡化核准流程，確保更快進入市場。此類策略措施提高了產品供應量，擴大了地域覆蓋範圍，並增強了整體市場地位。
• 新興市場應用日益廣泛：在發展中地區，由於醫療基礎設施的不斷改進和公眾意識的提高，胃腸道支架的應用正在不斷成長。各國政府和私營部門都在增加對醫療設施的投資，並致力於改善先進治療方案的可近性。本地化生產和經濟高效的解決方案使胃腸道支架更加普及。新興市場的這種成長顯著推動了全球市場的擴張，不僅帶來了新的收入來源，也推動了創新，以滿足不同患者的需求。

這些趨勢正在透過推動產品創新、擴大患者就醫管道和改善治療效果，改變整個胃腸道支架市場。先進材料的引入、策略合作以及新興市場滲透率的提高，正在推動市場持續成長。因此，市場競爭日益激烈、更加多元化，也更能滿足全球患者不斷變化的需求，最終提升醫療服務品質和病患生活品質。

目錄

第1章摘要整理

第2章 市場概覽

• 背景與分類
• 供應鏈

第3章 市場趨勢與預測分析

• 宏觀經濟趨勢與預測
• 產業促進因素與挑戰
• PESTLE分析
• 專利分析
• 法規環境

第4章：全球胃腸道支架市場：依產品類型分類

• 吸引力分析：依產品類型
• 膽道支架
• 食道支架
• 十二指腸支架
• 結腸支架

第5章 全球胃腸支架市場：依材料分類

• 吸引力分析：依材料分類
• 金屬支架
• 塑膠支架

第6章：全球胃腸道支架市場：依最終用途分類

• 吸引力分析：依最終用途分類
• 醫院
• 門診手術中心
• 專科診所

第7章 區域分析

第8章：北美胃腸支架市場

• 北美胃腸支架市場：依產品類型分類
• 北美胃腸支架市場：依最終用途分類
• 美國胃腸道支架市場
• 加拿大胃腸道支架市場
• 墨西哥胃腸道支架市場

第9章：歐洲胃腸支架市場

• 歐洲胃腸支架市場：依產品類型分類
• 歐洲胃腸道支架市場：依最終用途分類
• 德國胃腸道支架市場
• 法國胃腸道支架市場
• 義大利胃腸道支架市場
• 西班牙胃腸道支架市場
• 英國胃腸道支架市場

第10章：亞太地區胃腸支架市場

• 亞太地區胃腸支架市場：依產品類型分類
• 亞太地區胃腸支架市場：依最終用途分類
• 中國胃腸支架市場
• 印度胃腸道支架市場
• 日本胃腸道支架市場
• 韓國胃腸道支架市場
• 印尼胃腸道支架市場

第11章：世界其他地區的胃腸道支架市場

• 其他區域胃腸道支架市場：依產品類型分類
• 其他區域胃腸道支架市場：依最終用途分類。
• 中東胃腸道支架市場
• 南非胃腸道支架市場
• 非洲胃腸道支架市場

第12章 競爭分析

• 產品系列分析
• 業務整合
• 波特五力分析
• 市佔率分析

第13章 機會與策略分析

• 價值鏈分析
• 成長機會分析
• 新趨勢：全球胃腸支架市場
• 戰略分析

第14章：價值鏈中主要企業的公司概況

• 競爭分析概述
• Boston Scientific Corporation
• Cook Medical
• CR Bard, Inc.
• ELLA-CS, sro
• Taewoong Medical Co., Ltd.
• Olympus Corporation
• Becton, Dickinson and Company
• Merit Medical Systems, Inc.
• MI Tech Co., Ltd.
• ConMed Corporation

第15章附錄

The future of the global GI stent market looks promising with opportunities in the hospital, ambulatory surgical center, and specialty clinic markets. The global GI stent market is expected to reach an estimated $958 million by 2035 with a CAGR of 5.1% from 2026 to 2035. The major drivers for this market are the increasing prevalence of gastrointestinal disorders, the rising demand for minimally invasive treatments, and the growing adoption of advanced stent technologies.

• Lucintel forecasts that, within the product type category, biliary stent is expected to witness the highest growth over the forecast period.
• Within the end use category, hospital is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the GI Stent Market

The GI stent market is experiencing rapid growth driven by technological advancements, increasing prevalence of GI disorders, and a rising aging population worldwide. As healthcare providers seek minimally invasive solutions for complex GI conditions, innovative stent designs and materials are emerging to improve patient outcomes. Additionally, regulatory approvals and expanding applications are broadening market opportunities. These developments are transforming the landscape of GI stent deployment, making treatments more effective, accessible, and tailored to patient needs. Understanding these trends is crucial for stakeholders aiming to capitalize on the evolving market dynamics and improve clinical practices.

• Technological Innovation: The development of biodegradable and drug-eluting GI stents is revolutionizing treatment options. These advanced stents reduce the need for removal procedures and help prevent restenosis, respectively. Innovations in materials and design enhance flexibility, durability, and biocompatibility, leading to better patient comfort and outcomes. As research progresses, these innovations are expected to set new standards in GI stenting, expanding their applications and improving long-term efficacy.
• Increasing Prevalence of GI Disorders: Rising incidences of conditions such as esophageal cancer, strictures, and Crohn's disease are driving demand for GI stents. The growing global burden of these diseases, especially in aging populations, necessitates minimally invasive interventions. This trend boosts market growth as healthcare providers seek effective solutions to manage complex GI conditions, leading to increased adoption of stenting procedures across hospitals and clinics.
• Expanding Applications: Initially used primarily for malignant obstructions, GI stents are now increasingly employed in benign conditions, such as strictures and fistulas. This expansion broadens the market scope and encourages innovation in stent design tailored for different indications. The ability to treat a wider range of GI disorders with minimally invasive techniques enhances patient care and reduces hospitalization times, further fueling market growth.
• Regulatory Approvals and Reimbursement Policies: Enhanced regulatory support and favorable reimbursement policies are facilitating market expansion. Approval of new stent products by agencies like the FDA and EMA ensures safety and efficacy, encouraging adoption. Additionally, insurance coverage and reimbursement schemes make procedures more accessible, driving demand. These regulatory and policy developments are crucial for market players to introduce innovative products and expand their reach.
• Rising Adoption of Minimally Invasive Procedures: The shift from traditional surgical interventions to minimally invasive endoscopic procedures is a significant trend. GI stents play a central role in this transition, offering less painful, quicker recovery options for patients. This trend is supported by technological advancements and increasing clinician expertise, leading to higher procedure volumes. The focus on patient-centered care and cost-effectiveness further accelerates the adoption of GI stenting, reshaping treatment paradigms in gastroenterology.

In summary, these trends are collectively transforming the GI stent market by fostering innovation, expanding clinical applications, and improving patient outcomes. They are driving market growth, encouraging new product development, and reshaping treatment strategies in gastrointestinal healthcare.

Recent Developments in the GI Stent Market

The GI stent market is experiencing rapid growth driven by technological advancements, increasing prevalence of gastrointestinal disorders, and expanding healthcare infrastructure worldwide. Innovations in stent design and materials are improving patient outcomes, while rising awareness and diagnosis rates are boosting demand. Additionally, strategic collaborations and regulatory approvals are facilitating market expansion. These developments are transforming the landscape, offering new opportunities for manufacturers and healthcare providers to enhance treatment options and improve patients quality of life.

• Growing Demand for Minimally Invasive Procedures: The shift towards minimally invasive treatments is fueling the GI stent market. Patients prefer less invasive options due to reduced recovery times and lower complication risks. Technological innovations have led to the development of more flexible, durable, and biocompatible stents, making procedures safer and more effective. This trend is expanding the patient base and increasing adoption rates across hospitals and clinics globally, thereby driving market growth significantly.
• Innovation in Stent Materials and Design: Advances in biomaterials and design are revolutionizing GI stents. New materials like biodegradable and drug-eluting stents are improving patient outcomes by reducing complications such as restenosis and migration. Enhanced design features, including better flexibility and radiopacity, facilitate precise placement and monitoring. These innovations are expanding indications for use, attracting more healthcare providers, and boosting market revenue through improved efficacy and safety profiles.
• Increasing Prevalence of Gastrointestinal Disorders: Rising incidences of conditions like esophageal, gastric, and colorectal cancers, as well as strictures and obstructions, are escalating the demand for GI stents. Aging populations and lifestyle factors contribute to this trend. The growing burden of these disorders necessitates effective management options, positioning GI stents as essential tools. This increasing prevalence directly correlates with higher market sales and encourages ongoing research and development in the sector.
• Strategic Collaborations and Regulatory Approvals: Partnerships between biotech firms, medical device companies, and healthcare providers are accelerating innovation and market penetration. Regulatory approvals in emerging markets are opening new avenues for sales. These collaborations facilitate the development of advanced stent technologies and streamline approval processes, ensuring faster market entry. Such strategic moves are enhancing product availability, expanding geographic reach, and strengthening the overall market position.
• Rising Adoption in Emerging Markets: Developing regions are witnessing increased adoption of GI stents due to expanding healthcare infrastructure and rising awareness. Governments and the private sector are investing in healthcare facilities, improving access to advanced treatments. Local manufacturing and cost-effective solutions are making GI stents more accessible. This growth in emerging markets is significantly contributing to global market expansion, offering new revenue streams and fostering innovation tailored to diverse patient needs.

These developments are collectively transforming the GI stent market by enhancing product innovation, expanding patient access, and improving treatment outcomes. The integration of advanced materials, strategic collaborations, and increased adoption in emerging markets are driving sustained growth. As a result, the market is becoming more competitive, diverse, and capable of meeting the evolving needs of patients worldwide, ultimately improving healthcare delivery and patient quality of life.

Strategic Growth Opportunities in the GI Stent Market

The GI stent market is experiencing significant growth driven by increasing gastrointestinal disorders, technological advancements, and rising minimally invasive procedures. The demand for innovative, durable, and biocompatible stents is expanding across hospitals, clinics, and specialized care centers worldwide. Strategic collaborations, regulatory approvals, and rising healthcare expenditure further propel market expansion. This dynamic environment offers numerous opportunities for industry players to innovate, diversify, and capture new customer segments, ultimately improving patient outcomes and healthcare efficiency.

• Growing Incidence of Gastrointestinal Diseases Presents New Market Opportunities: The rising prevalence of conditions like esophageal, biliary, and colorectal cancers, along with benign strictures, fuels demand for GI stents. As these diseases become more common globally, the need for minimally invasive, effective treatment options increases. This trend encourages manufacturers to develop specialized stents tailored to different conditions, expanding the market scope and driving innovation in product design and application.
• Technological Innovations Enhance Stent Performance and Patient Outcomes: Advances such as drug-eluting, biodegradable, and self-expanding stents improve treatment efficacy and reduce complications. Integration of imaging guidance and customization options further optimizes placement and patient comfort. These innovations attract healthcare providers seeking better clinical results, thereby expanding market adoption. Continuous R&D efforts are expected to introduce next-generation solutions, opening new avenues for growth and differentiation within the industry.
• Increasing Adoption of Minimally Invasive Procedures Promotes Market Expansion: The shift from traditional surgical interventions to endoscopic and percutaneous techniques boosts demand for GI stents. These procedures offer reduced recovery times, lower complication rates, and improved patient experiences. As healthcare providers increasingly favor minimally invasive options, the market for specialized stents grows correspondingly. This trend encourages manufacturers to develop versatile, easy-to-use products compatible with various endoscopic systems, further fueling industry growth.
• Strategic Collaborations and Regulatory Approvals Accelerate Market Penetration: Partnerships between device manufacturers, research institutions, and healthcare providers facilitate product innovation and market access. Regulatory approvals in emerging markets open new customer bases and enhance credibility. These collaborations streamline development processes and ensure compliance with safety standards, fostering confidence among clinicians and patients. As a result, the market benefits from a broader product portfolio and increased adoption, supporting sustained growth and competitive positioning.
• Rising Healthcare Expenditure and Awareness Drive Market Growth: Increasing healthcare budgets and awareness about gastrointestinal health lead to higher procedural volumes and demand for advanced stents. Governments and private insurers are investing more in minimally invasive treatments, expanding access to GI stent procedures. Educational initiatives and patient advocacy also raise awareness, encouraging early diagnosis and intervention. This environment creates favorable conditions for market expansion, innovation, and increased revenue streams for industry stakeholders.

The overall impact of these opportunities is a robust, innovative, and expanding GI stent market. As technological, clinical, and economic factors align, industry players are positioned to capitalize on emerging trends, improve patient care, and achieve sustainable growth. This evolving landscape promises continued advancements and increased accessibility, ultimately transforming gastrointestinal healthcare worldwide.

GI Stent Market Driver and Challenges

The GI stent market is influenced by a variety of technological, economic, and regulatory factors that shape its growth trajectory. Advances in minimally invasive procedures and innovative stent designs have expanded treatment options, while the increasing prevalence of gastrointestinal disorders drives demand. Economic factors such as healthcare expenditure and insurance coverage impact accessibility and adoption. Regulatory frameworks ensure safety and efficacy but can also pose hurdles for market entry and product approval. Together, these drivers and challenges create a dynamic environment that influences market expansion, innovation, and competition, ultimately affecting patient outcomes and industry profitability.

The factors responsible for driving the GI stent market include:

• Technological Advancements: The development of innovative stent materials and designs, such as drug-eluting and biodegradable stents, has significantly improved treatment outcomes. These advancements enable minimally invasive procedures, reduce complication rates, and extend the lifespan of stents. As technology continues to evolve, clinicians can offer more effective and tailored solutions for gastrointestinal conditions, fueling market growth. The integration of imaging and navigation systems further enhances procedural precision, attracting healthcare providers to adopt these advanced options. Overall, technological progress is a key driver that sustains innovation and market expansion.
• Rising Prevalence of Gastrointestinal Disorders: Increasing incidences of conditions like esophageal strictures, tumors, and inflammatory bowel disease are driving demand for GI stents. Aging populations and lifestyle factors contribute to the rising burden of these disorders worldwide. As more patients require minimally invasive interventions, the need for effective stenting solutions grows. This trend is particularly prominent in emerging economies where healthcare infrastructure is improving. The growing patient pool directly correlates with increased market demand, encouraging manufacturers to innovate and expand their product portfolios to meet diverse clinical needs.
• Healthcare Infrastructure Development: Expansion and modernization of healthcare facilities, especially in developing regions, facilitate greater adoption of GI stenting procedures. Investments in hospitals, clinics, and specialized endoscopy centers improve access to advanced treatments. Additionally, training programs for healthcare professionals enhance procedural expertise, increasing confidence in using GI stents. This infrastructure development reduces procedural costs and improves patient outcomes, making stenting a preferred treatment option. As healthcare systems evolve, the market benefits from increased procedural volumes and broader geographic reach, supporting sustained growth.
• Increasing Healthcare Expenditure: Rising healthcare spending globally enables more patients to access advanced medical devices like GI stents. Governments and private insurers are investing in healthcare infrastructure and innovative treatments, which lower financial barriers for patients. This increased expenditure supports research and development, leading to the introduction of improved stent technologies. Moreover, higher reimbursement rates for minimally invasive procedures incentivize healthcare providers to adopt GI stents. Consequently, the market experiences growth driven by economic capacity and willingness to invest in cutting-edge gastrointestinal treatments.
• Growing Awareness and Diagnosis: Enhanced awareness about gastrointestinal diseases and improved diagnostic techniques, such as endoscopy and imaging, lead to earlier detection and intervention. Early diagnosis increases the likelihood of successful minimally invasive treatments using GI stents. Public health campaigns and medical education further promote awareness, expanding the patient base eligible for stenting procedures. This trend results in higher procedural volumes and stimulates market growth. Additionally, increased awareness encourages research and development efforts to create more effective and patient-friendly stent options, fostering innovation within the industry.

The challenges facing the GI stent market include:

• Stringent Regulatory Approvals: Navigating complex regulatory pathways for GI stents can delay product launches and increase costs. Regulatory agencies require extensive clinical data to demonstrate safety and efficacy, which can be time-consuming and expensive to obtain. Variations in approval processes across regions create additional hurdles for market entry and expansion. These regulatory challenges may hinder innovation and limit the availability of new products, impacting overall market growth. Companies must invest heavily in compliance and clinical trials, which can strain resources, especially for smaller players.
• High Cost of Advanced Stents: The development and manufacturing of innovative GI stents involve high costs, leading to higher prices for end-users. This can limit adoption in cost-sensitive markets and among healthcare providers with budget constraints. Additionally, reimbursement issues and insurance coverage limitations further restrict patient access to advanced stenting options. The high cost can also impact hospital procurement decisions, favoring more affordable alternatives. As a result, market growth may be impeded in regions where cost considerations outweigh clinical benefits, creating a barrier to widespread adoption.
• Competition and Market Saturation: The increasing number of players and product offerings intensifies competition within the GI stent market. Differentiating products becomes challenging, leading to price wars and reduced profit margins. Market saturation in developed regions may slow growth, prompting companies to seek opportunities in emerging markets. However, entering these markets involves overcoming regulatory, infrastructural, and awareness barriers. The competitive landscape necessitates continuous innovation and marketing efforts, which can strain resources and divert focus from product development, potentially hindering long-term growth prospects.

In summary, the GI stent market is shaped by rapid technological innovations, increasing disease prevalence, and expanding healthcare infrastructure, all of which promote growth. However, regulatory complexities, high costs, and intense competition pose significant challenges. These factors collectively influence market dynamics, requiring stakeholders to balance innovation with strategic planning. Overall, the markets future depends on how effectively companies can navigate these drivers and challenges to deliver safe, affordable, and innovative solutions that meet evolving clinical needs.

List of GI Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies GI stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the GI stent companies profiled in this report include-

• Boston Scientific Corporation
• Cook Medical
• C.R. Bard, Inc.
• ELLA-CS, s.r.o.
• Taewoong Medical Co., Ltd.
• Olympus Corporation
• Becton, Dickinson and Company
• Merit Medical Systems, Inc.
• M.I. Tech Co., Ltd.
• ConMed Corporation

GI Stent Market by Segment

The study includes a forecast for the global GI stent market by product type, material, end use, and region.

GI Stent Market by Product Type [Value from 2019 to 2035]:

• Biliary Stents
• Esophageal Stents
• Duodenal Stents
• Colonic Stents

GI Stent Market by Material [Value from 2019 to 2035]:

• Metal Stents
• Plastic Stents

GI Stent Market by End Use [Value from 2019 to 2035]:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

GI Stent Market by Region [Value from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the GI Stent Market

The GI stent market has experienced significant advancements driven by technological innovations, increasing prevalence of gastrointestinal disorders, and expanding healthcare infrastructure worldwide. As countries adopt new medical technologies and improve patient care, the market dynamics are shifting, with notable growth in developed and developing regions. Regulatory approvals, research developments, and rising awareness about minimally invasive procedures are also influencing market trends. These developments reflect a broader trend toward improved treatment options and personalized healthcare solutions for gastrointestinal conditions, impacting the global landscape of GI stent utilization and innovation.

• United States: The US market has seen rapid adoption of advanced GI stents with innovations such as drug-eluting and biodegradable options. Increased investment in research and development, along with favorable reimbursement policies, has driven growth. The rising prevalence of gastrointestinal cancers and strict regulatory standards have further propelled market expansion. Additionally, the integration of minimally invasive procedures and technological improvements in stent design have enhanced patient outcomes and procedural success rates.
• China: China's GI stent market is experiencing robust growth due to increasing healthcare infrastructure and rising awareness of gastrointestinal diseases. The government's focus on healthcare reforms and expanding insurance coverage has improved access to advanced treatments. Local manufacturers are gaining market share by offering cost-effective, innovative stents, including biodegradable and self-expanding variants. The growing prevalence of gastrointestinal disorders, coupled with a rising geriatric population, is fueling demand for minimally invasive solutions.
• Germany: Germany's market benefits from a well-established healthcare system and high adoption of innovative medical devices. The focus on quality and safety standards has led to the approval of advanced GI stents, including those with anti-migration features. Increasing prevalence of gastrointestinal conditions and a strong emphasis on research and clinical trials are driving market growth. Moreover, collaborations between healthcare providers and device manufacturers are fostering innovation and expanding the availability of specialized stents.
• India: The Indian GI stent market is expanding rapidly due to increasing cases of gastrointestinal cancers and disorders. Rising healthcare awareness, improved infrastructure, and government initiatives to promote affordable healthcare are key factors. Local manufacturers are introducing cost-effective, innovative stents to meet the growing demand. The adoption of minimally invasive procedures and the increasing number of hospitals equipped with advanced endoscopy facilities are further boosting market growth.
• Japan: Japan's market is characterized by high technological adoption and a focus on minimally invasive treatments. The aging population has led to increased cases of gastrointestinal diseases, driving demand for advanced stents. Japan's stringent regulatory environment ensures high-quality standards, fostering innovation in biodegradable and drug-eluting stents. Collaborations between research institutions and industry players are accelerating the development of next-generation GI stents, with a focus on improving patient comfort and treatment efficacy.

Features of the Global GI Stent Market

• Market Size Estimates: GI stent market size estimation in terms of value ($M).
• Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
• Segmentation Analysis: GI stent market size by product type, material, end use, and region in terms of value ($M).
• Regional Analysis: GI stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different product types, materials, end uses, and regions for the GI stent market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the GI stent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the GI stent market by product type (biliary stents, esophageal stents, duodenal stents, and colonic stents), material (metal stents and plastic stents), end use (hospitals, ambulatory surgical centers, and specialty clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global GI Stent Market by Product Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Product Type
• 4.3 Biliary Stents : Trends and Forecast (2019-2035)
• 4.4 Esophageal Stents : Trends and Forecast (2019-2035)
• 4.5 Duodenal Stents : Trends and Forecast (2019-2035)
• 4.6 Colonic Stents : Trends and Forecast (2019-2035)

5. Global GI Stent Market by Material

• 5.1 Overview
• 5.2 Attractiveness Analysis by Material
• 5.3 Metal Stents : Trends and Forecast (2019-2035)
• 5.4 Plastic Stents : Trends and Forecast (2019-2035)

6. Global GI Stent Market by End Use

• 6.1 Overview
• 6.2 Attractiveness Analysis by End Use
• 6.3 Hospitals : Trends and Forecast (2019-2035)
• 6.4 Ambulatory Surgical Centers : Trends and Forecast (2019-2035)
• 6.5 Specialty Clinics : Trends and Forecast (2019-2035)

7. Regional Analysis

• 7.1 Overview
• 7.2 Global GI Stent Market by Region

8. North American GI Stent Market

• 8.1 Overview
• 8.2 North American GI Stent Market by Product Type
• 8.3 North American GI Stent Market by End Use
• 8.4 The United States GI Stent Market
• 8.5 Canadian GI Stent Market
• 8.6 Mexican GI Stent Market

9. European GI Stent Market

• 9.1 Overview
• 9.2 European GI Stent Market by Product Type
• 9.3 European GI Stent Market by End Use
• 9.4 German GI Stent Market
• 9.5 French GI Stent Market
• 9.6 Italian GI Stent Market
• 9.7 Spanish GI Stent Market
• 9.8 The United Kingdom GI Stent Market

10. APAC GI Stent Market

• 10.1 Overview
• 10.2 APAC GI Stent Market by Product Type
• 10.3 APAC GI Stent Market by End Use
• 10.4 Chinese GI Stent Market
• 10.5 Indian GI Stent Market
• 10.6 Japanese GI Stent Market
• 10.7 South Korean GI Stent Market
• 10.8 Indonesian GI Stent Market

11. ROW GI Stent Market

• 11.1 Overview
• 11.2 ROW GI Stent Market by Product Type
• 11.3 ROW GI Stent Market by End Use
• 11.4 Middle Eastern GI Stent Market
• 11.5 South American GI Stent Market
• 11.6 African GI Stent Market

12. Competitor Analysis

• 12.1 Product Portfolio Analysis
• 12.2 Operational Integration
• 12.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 12.4 Market Share Analysis

13. Opportunities & Strategic Analysis

• 13.1 Value Chain Analysis
• 13.2 Growth Opportunity Analysis
  • 13.2.1 Growth Opportunity by Product Type
  • 13.2.2 Growth Opportunity by Material
  • 13.2.3 Growth Opportunity by End Use
• 13.3 Emerging Trends in the Global GI Stent Market
• 13.4 Strategic Analysis
  • 13.4.1 New Product Development
  • 13.4.2 Certification and Licensing
  • 13.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

14. Company Profiles of the Leading Players Across the Value Chain

• 14.1 Competitive Analysis Overview
• 14.2 Boston Scientific Corporation
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.3 Cook Medical
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.4 C.R. Bard, Inc.
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.5 ELLA-CS, s.r.o.
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.6 Taewoong Medical Co., Ltd.
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.7 Olympus Corporation
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.8 Becton, Dickinson and Company
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.9 Merit Medical Systems, Inc.
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.10 M.I. Tech Co., Ltd.
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.11 ConMed Corporation
  • Company Overview
  • GI Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

15. Appendix

• 15.1 List of Figures
• 15.2 List of Tables
• 15.3 Research Methodology
• 15.4 Disclaimer
• 15.5 Copyright
• 15.6 Abbreviations and Technical Units
• 15.7 About Us
• 15.8 Contact Us

List of Figures

• Figure 1.1: Trends and Forecast for the Global GI Stent Market
• Figure 2.1: Usage of GI Stent Market
• Figure 2.2: Classification of the Global GI Stent Market
• Figure 2.3: Supply Chain of the Global GI Stent Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 3.19: Driver and Challenges of the GI Stent Market
• Figure 4.1: Global GI Stent Market by Product Type in 2019, 2025, and 2035
• Figure 4.2: Trends of the Global GI Stent Market ($B) by Product Type
• Figure 4.3: Forecast for the Global GI Stent Market ($B) by Product Type
• Figure 4.4: Trends and Forecast for Biliary Stents in the Global GI Stent Market (2019-2035)
• Figure 4.5: Trends and Forecast for Esophageal Stents in the Global GI Stent Market (2019-2035)
• Figure 4.6: Trends and Forecast for Duodenal Stents in the Global GI Stent Market (2019-2035)
• Figure 4.7: Trends and Forecast for Colonic Stents in the Global GI Stent Market (2019-2035)
• Figure 5.1: Global GI Stent Market by Material in 2019, 2025, and 2035
• Figure 5.2: Trends of the Global GI Stent Market ($B) by Material
• Figure 5.3: Forecast for the Global GI Stent Market ($B) by Material
• Figure 5.4: Trends and Forecast for Metal Stents in the Global GI Stent Market (2019-2035)
• Figure 5.5: Trends and Forecast for Plastic Stents in the Global GI Stent Market (2019-2035)
• Figure 6.1: Global GI Stent Market by End Use in 2019, 2025, and 2035
• Figure 6.2: Trends of the Global GI Stent Market ($B) by End Use
• Figure 6.3: Forecast for the Global GI Stent Market ($B) by End Use
• Figure 6.4: Trends and Forecast for Hospitals in the Global GI Stent Market (2019-2035)
• Figure 6.5: Trends and Forecast for Ambulatory Surgical Centers in the Global GI Stent Market (2019-2035)
• Figure 6.6: Trends and Forecast for Specialty Clinics in the Global GI Stent Market (2019-2035)
• Figure 7.1: Trends of the Global GI Stent Market ($B) by Region (2019-2025)
• Figure 7.2: Forecast for the Global GI Stent Market ($B) by Region (2026-2035)
• Figure 8.1: Trends and Forecast for the North American GI Stent Market (2019-2035)
• Figure 8.2: North American GI Stent Market by Product Type in 2019, 2025, and 2035
• Figure 8.3: Trends of the North American GI Stent Market ($B) by Product Type (2019-2025)
• Figure 8.4: Forecast for the North American GI Stent Market ($B) by Product Type (2026-2035)
• Figure 8.5: North American GI Stent Market by Material in 2019, 2025, and 2035
• Figure 8.6: Trends of the North American GI Stent Market ($B) by Material (2019-2025)
• Figure 8.7: Forecast for the North American GI Stent Market ($B) by Material (2026-2035)
• Figure 8.8: North American GI Stent Market by End Use in 2019, 2025, and 2035
• Figure 8.9: Trends of the North American GI Stent Market ($B) by End Use (2019-2025)
• Figure 8.10: Forecast for the North American GI Stent Market ($B) by End Use (2026-2035)
• Figure 8.11: Trends and Forecast for the United States GI Stent Market ($B) (2019-2035)
• Figure 8.12: Trends and Forecast for the Mexican GI Stent Market ($B) (2019-2035)
• Figure 8.13: Trends and Forecast for the Canadian GI Stent Market ($B) (2019-2035)
• Figure 9.1: Trends and Forecast for the European GI Stent Market (2019-2035)
• Figure 9.2: European GI Stent Market by Product Type in 2019, 2025, and 2035
• Figure 9.3: Trends of the European GI Stent Market ($B) by Product Type (2019-2025)
• Figure 9.4: Forecast for the European GI Stent Market ($B) by Product Type (2026-2035)
• Figure 9.5: European GI Stent Market by Material in 2019, 2025, and 2035
• Figure 9.6: Trends of the European GI Stent Market ($B) by Material (2019-2025)
• Figure 9.7: Forecast for the European GI Stent Market ($B) by Material (2026-2035)
• Figure 9.8: European GI Stent Market by End Use in 2019, 2025, and 2035
• Figure 9.9: Trends of the European GI Stent Market ($B) by End Use (2019-2025)
• Figure 9.10: Forecast for the European GI Stent Market ($B) by End Use (2026-2035)
• Figure 9.11: Trends and Forecast for the German GI Stent Market ($B) (2019-2035)
• Figure 9.12: Trends and Forecast for the French GI Stent Market ($B) (2019-2035)
• Figure 9.13: Trends and Forecast for the Spanish GI Stent Market ($B) (2019-2035)
• Figure 9.14: Trends and Forecast for the Italian GI Stent Market ($B) (2019-2035)
• Figure 9.15: Trends and Forecast for the United Kingdom GI Stent Market ($B) (2019-2035)
• Figure 10.1: Trends and Forecast for the APAC GI Stent Market (2019-2035)
• Figure 10.2: APAC GI Stent Market by Product Type in 2019, 2025, and 2035
• Figure 10.3: Trends of the APAC GI Stent Market ($B) by Product Type (2019-2025)
• Figure 10.4: Forecast for the APAC GI Stent Market ($B) by Product Type (2026-2035)
• Figure 10.5: APAC GI Stent Market by Material in 2019, 2025, and 2035
• Figure 10.6: Trends of the APAC GI Stent Market ($B) by Material (2019-2025)
• Figure 10.7: Forecast for the APAC GI Stent Market ($B) by Material (2026-2035)
• Figure 10.8: APAC GI Stent Market by End Use in 2019, 2025, and 2035
• Figure 10.9: Trends of the APAC GI Stent Market ($B) by End Use (2019-2025)
• Figure 10.10: Forecast for the APAC GI Stent Market ($B) by End Use (2026-2035)
• Figure 10.11: Trends and Forecast for the Japanese GI Stent Market ($B) (2019-2035)
• Figure 10.12: Trends and Forecast for the Indian GI Stent Market ($B) (2019-2035)
• Figure 10.13: Trends and Forecast for the Chinese GI Stent Market ($B) (2019-2035)
• Figure 10.14: Trends and Forecast for the South Korean GI Stent Market ($B) (2019-2035)
• Figure 10.15: Trends and Forecast for the Indonesian GI Stent Market ($B) (2019-2035)
• Figure 11.1: Trends and Forecast for the ROW GI Stent Market (2019-2035)
• Figure 11.2: ROW GI Stent Market by Product Type in 2019, 2025, and 2035
• Figure 11.3: Trends of the ROW GI Stent Market ($B) by Product Type (2019-2025)
• Figure 11.4: Forecast for the ROW GI Stent Market ($B) by Product Type (2026-2035)
• Figure 11.5: ROW GI Stent Market by Material in 2019, 2025, and 2035
• Figure 11.6: Trends of the ROW GI Stent Market ($B) by Material (2019-2025)
• Figure 11.7: Forecast for the ROW GI Stent Market ($B) by Material (2026-2035)
• Figure 11.8: ROW GI Stent Market by End Use in 2019, 2025, and 2035
• Figure 11.9: Trends of the ROW GI Stent Market ($B) by End Use (2019-2025)
• Figure 11.10: Forecast for the ROW GI Stent Market ($B) by End Use (2026-2035)
• Figure 11.11: Trends and Forecast for the Middle Eastern GI Stent Market ($B) (2019-2035)
• Figure 11.12: Trends and Forecast for the South American GI Stent Market ($B) (2019-2035)
• Figure 11.13: Trends and Forecast for the African GI Stent Market ($B) (2019-2035)
• Figure 12.1: Porter's Five Forces Analysis of the Global GI Stent Market
• Figure 12.2: Market Share (%) of Top Players in the Global GI Stent Market (2025)
• Figure 13.1: Growth Opportunities for the Global GI Stent Market by Product Type
• Figure 13.2: Growth Opportunities for the Global GI Stent Market by Material
• Figure 13.3: Growth Opportunities for the Global GI Stent Market by End Use
• Figure 13.4: Growth Opportunities for the Global GI Stent Market by Region
• Figure 13.5: Emerging Trends in the Global GI Stent Market

List of Tables

• Table 1.1: Growth Rate (%, 2024-2025) and CAGR (%, 2026-2035) of the GI Stent Market by Product Type, Material, and End Use
• Table 1.2: Attractiveness Analysis for the GI Stent Market by Region
• Table 1.3: Global GI Stent Market Parameters and Attributes
• Table 3.1: Trends of the Global GI Stent Market (2019-2025)
• Table 3.2: Forecast for the Global GI Stent Market (2026-2035)
• Table 4.1: Attractiveness Analysis for the Global GI Stent Market by Product Type
• Table 4.2: Market Size and CAGR of Various Product Type in the Global GI Stent Market (2019-2025)
• Table 4.3: Market Size and CAGR of Various Product Type in the Global GI Stent Market (2026-2035)
• Table 4.4: Trends of Biliary Stents in the Global GI Stent Market (2019-2025)
• Table 4.5: Forecast for Biliary Stents in the Global GI Stent Market (2026-2035)
• Table 4.6: Trends of Esophageal Stents in the Global GI Stent Market (2019-2025)
• Table 4.7: Forecast for Esophageal Stents in the Global GI Stent Market (2026-2035)
• Table 4.8: Trends of Duodenal Stents in the Global GI Stent Market (2019-2025)
• Table 4.9: Forecast for Duodenal Stents in the Global GI Stent Market (2026-2035)
• Table 4.10: Trends of Colonic Stents in the Global GI Stent Market (2019-2025)
• Table 4.11: Forecast for Colonic Stents in the Global GI Stent Market (2026-2035)
• Table 5.1: Attractiveness Analysis for the Global GI Stent Market by Material
• Table 5.2: Market Size and CAGR of Various Material in the Global GI Stent Market (2019-2025)
• Table 5.3: Market Size and CAGR of Various Material in the Global GI Stent Market (2026-2035)
• Table 5.4: Trends of Metal Stents in the Global GI Stent Market (2019-2025)
• Table 5.5: Forecast for Metal Stents in the Global GI Stent Market (2026-2035)
• Table 5.6: Trends of Plastic Stents in the Global GI Stent Market (2019-2025)
• Table 5.7: Forecast for Plastic Stents in the Global GI Stent Market (2026-2035)
• Table 6.1: Attractiveness Analysis for the Global GI Stent Market by End Use
• Table 6.2: Market Size and CAGR of Various End Use in the Global GI Stent Market (2019-2025)
• Table 6.3: Market Size and CAGR of Various End Use in the Global GI Stent Market (2026-2035)
• Table 6.4: Trends of Hospitals in the Global GI Stent Market (2019-2025)
• Table 6.5: Forecast for Hospitals in the Global GI Stent Market (2026-2035)
• Table 6.6: Trends of Ambulatory Surgical Centers in the Global GI Stent Market (2019-2025)
• Table 6.7: Forecast for Ambulatory Surgical Centers in the Global GI Stent Market (2026-2035)
• Table 6.8: Trends of Specialty Clinics in the Global GI Stent Market (2019-2025)
• Table 6.9: Forecast for Specialty Clinics in the Global GI Stent Market (2026-2035)
• Table 7.1: Market Size and CAGR of Various Regions in the Global GI Stent Market (2019-2025)
• Table 7.2: Market Size and CAGR of Various Regions in the Global GI Stent Market (2026-2035)
• Table 8.1: Trends of the North American GI Stent Market (2019-2025)
• Table 8.2: Forecast for the North American GI Stent Market (2026-2035)
• Table 8.3: Market Size and CAGR of Various Product Type in the North American GI Stent Market (2019-2025)
• Table 8.4: Market Size and CAGR of Various Product Type in the North American GI Stent Market (2026-2035)
• Table 8.5: Market Size and CAGR of Various Material in the North American GI Stent Market (2019-2025)
• Table 8.6: Market Size and CAGR of Various Material in the North American GI Stent Market (2026-2035)
• Table 8.7: Market Size and CAGR of Various End Use in the North American GI Stent Market (2019-2025)
• Table 8.8: Market Size and CAGR of Various End Use in the North American GI Stent Market (2026-2035)
• Table 8.9: Trends and Forecast for the United States GI Stent Market (2019-2035)
• Table 8.10: Trends and Forecast for the Mexican GI Stent Market (2019-2035)
• Table 8.11: Trends and Forecast for the Canadian GI Stent Market (2019-2035)
• Table 9.1: Trends of the European GI Stent Market (2019-2025)
• Table 9.2: Forecast for the European GI Stent Market (2026-2035)
• Table 9.3: Market Size and CAGR of Various Product Type in the European GI Stent Market (2019-2025)
• Table 9.4: Market Size and CAGR of Various Product Type in the European GI Stent Market (2026-2035)
• Table 9.5: Market Size and CAGR of Various Material in the European GI Stent Market (2019-2025)
• Table 9.6: Market Size and CAGR of Various Material in the European GI Stent Market (2026-2035)
• Table 9.7: Market Size and CAGR of Various End Use in the European GI Stent Market (2019-2025)
• Table 9.8: Market Size and CAGR of Various End Use in the European GI Stent Market (2026-2035)
• Table 9.9: Trends and Forecast for the German GI Stent Market (2019-2035)
• Table 9.10: Trends and Forecast for the French GI Stent Market (2019-2035)
• Table 9.11: Trends and Forecast for the Spanish GI Stent Market (2019-2035)
• Table 9.12: Trends and Forecast for the Italian GI Stent Market (2019-2035)
• Table 9.13: Trends and Forecast for the United Kingdom GI Stent Market (2019-2035)
• Table 10.1: Trends of the APAC GI Stent Market (2019-2025)
• Table 10.2: Forecast for the APAC GI Stent Market (2026-2035)
• Table 10.3: Market Size and CAGR of Various Product Type in the APAC GI Stent Market (2019-2025)
• Table 10.4: Market Size and CAGR of Various Product Type in the APAC GI Stent Market (2026-2035)
• Table 10.5: Market Size and CAGR of Various Material in the APAC GI Stent Market (2019-2025)
• Table 10.6: Market Size and CAGR of Various Material in the APAC GI Stent Market (2026-2035)
• Table 10.7: Market Size and CAGR of Various End Use in the APAC GI Stent Market (2019-2025)
• Table 10.8: Market Size and CAGR of Various End Use in the APAC GI Stent Market (2026-2035)
• Table 10.9: Trends and Forecast for the Japanese GI Stent Market (2019-2035)
• Table 10.10: Trends and Forecast for the Indian GI Stent Market (2019-2035)
• Table 10.11: Trends and Forecast for the Chinese GI Stent Market (2019-2035)
• Table 10.12: Trends and Forecast for the South Korean GI Stent Market (2019-2035)
• Table 10.13: Trends and Forecast for the Indonesian GI Stent Market (2019-2035)
• Table 11.1: Trends of the ROW GI Stent Market (2019-2025)
• Table 11.2: Forecast for the ROW GI Stent Market (2026-2035)
• Table 11.3: Market Size and CAGR of Various Product Type in the ROW GI Stent Market (2019-2025)
• Table 11.4: Market Size and CAGR of Various Product Type in the ROW GI Stent Market (2026-2035)
• Table 11.5: Market Size and CAGR of Various Material in the ROW GI Stent Market (2019-2025)
• Table 11.6: Market Size and CAGR of Various Material in the ROW GI Stent Market (2026-2035)
• Table 11.7: Market Size and CAGR of Various End Use in the ROW GI Stent Market (2019-2025)
• Table 11.8: Market Size and CAGR of Various End Use in the ROW GI Stent Market (2026-2035)
• Table 11.9: Trends and Forecast for the Middle Eastern GI Stent Market (2019-2035)
• Table 11.10: Trends and Forecast for the South American GI Stent Market (2019-2035)
• Table 11.11: Trends and Forecast for the African GI Stent Market (2019-2035)
• Table 12.1: Product Mapping of GI Stent Suppliers Based on Segments
• Table 12.2: Operational Integration of GI Stent Manufacturers
• Table 12.3: Rankings of Suppliers Based on GI Stent Revenue
• Table 13.1: New Product Launches by Major GI Stent Producers (2019-2025)
• Table 13.2: Certification Acquired by Major Competitor in the Global GI Stent Market